investors.portola.com Review:

Portola Pharmaceuticals, Inc. - Investors - Investor Relations Home - Portola Pharmaceuticals is a biopharmaceutical company developing innovative drugs for the treatment of cardiovascular and inflammatory diseases PortolaÕs two most advanced programs are in Phase II clinical trials: 1) betrixaban, an oral, once-daily Factor Xa inhibitor being developed for stroke prevention in patients with atrial fibrillation (SPAF) and for prevention of venous thromboembolism (VTE) in various patient populations, and 2) elinogrel, a direct-acting, reversible oral and i.v. ADP receptor antagonist initially being developed for patients with acute coronary syndrome (ACS).

Country: 95.100.248.90, Europe,

  • Nancy Saltzman - BRIGHT!

    This flashlight is so powerful that I can see across the street from my deck and figure out why my dogs are barking!

  • blade - ... lights were wired backwards from factory and connections were bad. Whomever soldered them did a poor job-Connections came ..

    The lights were wired backwards from factory and connections were bad. Whomever soldered them did a poor job-Connections came lose. I did not mistreat them. I ended up splicing wires and soldering myself. Additionally, I have a 2016 Jeep Wrangler Sahara so I also needed the antiflicker module, which fixed the problem.

  • Stephen Carter - ... a couple of weeks now and have nothing but good things to say

    I have been taking Myobuild for a couple of weeks now and have nothing but good things to say. Tastes great, no weird tingling like you get from other supplements. I have been stacking with a few other products and have been very pleased with the results. My recovery is much faster. I am lifting and pushing more weight. All of this combined makes me even more motivated to get me back in the box and kill it.